Introduction
============

*Shigella sonnei*, together with *Shigella flexneri*, is responsible for more than 90% of shigellosis cases in the US ([@evy168-B53]), causing an estimated 500,000 infections, 6,000 hospitalizations and 70 deaths annually ([@evy168-B35]; [@evy168-B15]). Historically, *S. sonnei* has been responsible for bacillary dysentery in developed countries but its recent emergence and spread into developing countries over the last decades has raised major public health concerns ([@evy168-B63]). Unlike other *Shigella* spp., *S. sonnei* is genetically homogenous ([@evy168-B26]) and descended from a clonal, rapid-evolving multidrug resistant (MDR) ancestor that diversified into distinct lineages ([@evy168-B18]). MDR strains that confer resistance to different classes of antibiotics have been described ([@evy168-B20]; [@evy168-B30]).

An important virulence factor in *Shigella* spp. is the Shiga toxin, first discovered in the 19th century in a *Shigella dysenteriae* clinical isolate by Kiyoshi Shiga ([@evy168-B62]), which is also a hallmark of Shiga toxin-producing *Escherichia coli* (STEC) ([@evy168-B13]; [@evy168-B51]). Although not all *Shigella* spp. or *S. sonnei* isolates are shigatoxigenic, Stx can be laterally acquired through Stx phage infection, either from (STEC) or Stx-producing *Shigella* strains ([@evy168-B56]; [@evy168-B40]). Other key virulence determinants of *Shigella* are long polar fimbriae (*lpfA*), P-related fimbria regulatory gene (*prfB*), *Shigella* IgA-like protease homolog (*sigA*), plasmid-encoded enterotoxin (*senB*), glutamate decarboxylase (*gad*), invasion protein S. *flexneri* (*ipaD*), or VirF transcriptional activator (*virF*), among others as reviewed in [@evy168-B34].

Strain 866 has been found to be highly susceptible to infection by a range of phages, including Cytolethal Distending Toxin and Stx-converting prophages found in STEC, as previously demonstrated ([@evy168-B37]; [@evy168-B2]; [@evy168-B19]). This observation highlights the potential epidemiological role of this particular strain in the acquisition and spread of phage-borne pathogenicity factors into larger host-pathogen populations by means of bacteriophage transduction. The availability of the closed high-quality 866 genome presented in this study is foundational to further elucidate genome characteristics correlated with its virulence, resistance, and bacteriophage susceptibility.

Materials and Methods
=====================

*Shigella sonnei* 866
---------------------

The clinical *S. sonnei* strain 866 was isolated from human feces in September of 2000 in Hospital de la Santa Creu i Sant Pau in Barcelona, Spain. Species identification was confirmed by an array of biochemical tests (API 20E, BioMérieux, Marcy-l\'Étoile, France) ([supplementary table 1](#sup1){ref-type="supplementary-material"}), following the manufacturer's instructions. As demonstrated previously, strain 886 is highly susceptible to lysogenic phage infection and prophage genome incorporation ([@evy168-B37]; [@evy168-B2]; [@evy168-B19]).

Genome Sequencing, Assembly, and Annotation
-------------------------------------------

The strain was cultured in Luria-Bertani broth (Fisher Scientific, Thermo Fisher Scientific, Asheville, NC, USA) overnight at 37 °C in a shaker (180 rpm). Total genomic DNA was extracted from the overnight culture using the QIAamp DNA Mini Kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer\'s protocol. To close the genome, we pursued a hybrid approach using long-read PacBio RS II and short-read Illumina MiSeq sequencing. Briefly, for PacBio sequencing, genomic DNA was sheared into 20-kb fragments using g-TUBE (Covaris, Inc., Woburn, MA, USA). The library was prepared based on the 20-kb PacBio sample preparation protocol and sequenced using P6/C4 chemistry on four single-molecule real-time (SMRT) cells with a 240-min collection time. The continuous long-read data were de novo assembled using the PacBio hierarchical genome assembly process (HGAP version 3.0) ([@evy168-B12]) with default parameters in SMRT Analysis v2.3.0, including consensus polishing with Quiver ([@evy168-B12]). For Illumina sequencing, a paired-end library was prepared using the NxSeq AmpFREE Low DNA Library Kit (Lucigen) and sequenced with 250-bp read length using the MiSeq Reagent kit v2 500-cycle (Illumina) following the manufacturer's guidelines. Illumina reads were utilized for PacBio sequence error correction using Pilon ([@evy168-B64]). The chromosomal and plasmid origin of replication, *oriC* (<http://tubic.tju.edu.cn/Ori-Finder/>; last accessed August 06, 2018) ([@evy168-B14]) and *repA*, respectively, were determined and designated as the zero point of the closed molecules prior to annotation using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) ([@evy168-B59]).

Comparative Phylogenomics
-------------------------

After assembly and annotation, virulence and antibiotic resistance (AR) genes in the 866 chromosome and plasmid were detected *in silico* by VirulenceFinder (<https://cge.cbs.dtu.dk/services/VirulenceFinder/>; last accessed August 06, 2018) ([@evy168-B23]) and ResFinder (<https://cge.cbs.dtu.dk/services/ResFinder/>; last accessed August 06, 2018) ([@evy168-B66]), respectively. Prophages and plasmid incompatibility groups were identified using PHASTER ([@evy168-B68]; [@evy168-B5]) and PlasmidFinder (<https://cge.cbs.dtu.dk/services/PlasmidFinder/>; last accessed August 06, 2018) ([@evy168-B9]), respectively. BLASTn ([@evy168-B3]) of the complete p866 sequence against the NCBI non-redundant database identified a number of *Shigella* and *E. coli* IncB/O/K/Z-type plasmids as closest phylogenetic relatives. Respective plasmid gene inventories were compared with BLAST atlas in the GView server (<https://server.gview.ca>; last accessed August 06, 2018) ([@evy168-B47]). To further establish the phylogenetic relatedness of strain 866 within *Shigella*, we selected a total of 26 representative *S. sonnei, S. flexneri, S. dysenteriae*, and *S. boydii* genomes from NCBI ([supplementary table 2](#sup1){ref-type="supplementary-material"}) to capture the plasticity within the four established *Shigella* species ([@evy168-B52]). The phylogeny was inferred from the whole genome alignment using Mugsy ([@evy168-B4]) and RAxML ([@evy168-B55]) with 100 bootstrap replicates. The tree was visualized in Geneious ([@evy168-B28]) and decorated with strain-associated metadata in Evolview ([@evy168-B67]; [@evy168-B17]).

Results and Discussion
======================

Pathogenome Architecture and Inventory
--------------------------------------

A hybrid strategy using long-read PacBio and short-read Illumina technologies allowed us to sequence the *S. sonnei* strain 866 genome to closure with high chromosomal and plasmid coverage of 107x and 134x. The genome is comprised of a 4,849,628 bp chromosome and a 113,079 bp MDR plasmid, termed p866, with an average GC content of 51% for both molecules. Strain 866 lacks the large virulence plasmid pSS, which encodes the *wbg* Phase I O antigen cluster, and thus features a rough colony morphology ([@evy168-B29]; [@evy168-B8]).

Annotation with PGAP ([@evy168-B59]) predicted a total of 4,482 coding sequences (CDS), 96 tRNAs, and 22 rRNAs. The annotated chromosome and plasmid p866 have been deposited in GenBank under accession numbers CP022672 and CP022673, respectively.

Whole Genome Phylogenetic Analysis
----------------------------------

To determine the evolutionary relationship of *S. sonnei* strain 866 within *Shigella*, we established a phylogenetic framework by including representative *S. sonnei, S. flexneri, S. boydii*, and *S. dysenteriae* genomes ([supplementary table 2](#sup1){ref-type="supplementary-material"}) to capture diversity among the four species ([fig. 1](#evy168-F1){ref-type="fig"}). The resulting whole genome-based phylogeny positions strain 866 into clade S2, a group exclusively comprised of *S. sonnei* isolates, indicative of the clonal nature of *S*. *sonnei* ([@evy168-B26]). The genetic homogeneity of this cluster was further confirmed by whole genome comparison, as evidenced by the high degree of the overall nucleotide sequence similarity in the genomes ([supplementary fig. 1](#sup1){ref-type="supplementary-material"}). The tree topology partitions the isolates into five distinct phylogenetic clusters (S1--S5), as previously established ([@evy168-B52])*.* With the exception of the monophyletic *S. sonnei* clade S2 ([fig. 1](#evy168-F1){ref-type="fig"}), we note here that the *Shigella* species designation, historically based on clinical outcome, often does not corroborate with the phylogenetic clustering, as different species make-up clades S1 and S3--S5. Further, pathovar boundaries in *Shigella* and *E. coli* are clearly obstructed by mobile virulence and resistance factors that can be acquired or lost through independent evolutionary events ([@evy168-B27]; [@evy168-B18]; [@evy168-B51]; [@evy168-B44]).

![Whole genome phylogeny of representative *Shigella* spp. strains. Genomes of a total of 27 *Shigella* strains (*S. sonnei* SS, blue; *S. boydii* SB, orange; *S. flexneri* SF, purple; and *S. dysenteriae* SD, green) including *S. sonnei* 866, highlighted by a red box, were aligned with Mugsy ([@evy168-B4]). The phylogenetic tree was inferred using RAxML ([@evy168-B55]) with a 100 bootstrap replicates and decorated with the corresponding metadata in Evolview ([@evy168-B17]). Only bootstrap values above 90 are shown in the tree. The tree topology partitions the isolates into five distinct clusters (S1--S5). Unlike the monophyletic *S. sonnei* clade S2, the phylogenetic clustering does not corroborate with the *Shigella* species designation.](evy168f1){#evy168-F1}

Virulence and Resistance Profile of *S. sonnei* 866
---------------------------------------------------

The *Shigella* genome is highly dynamic, and mobile elements are major drivers of the *S. sonnei* pathogenome evolution ([@evy168-B22]; [@evy168-B11]; [@evy168-B24]). Phage profiling by PHASTER ([@evy168-B5]) showed that strain 866 carries a highly diverse inventory of 17 prophages, including seven complete and several predicted prophage remnants. Details of respective prophage chromosomal position, length, GC content, and number of predicted CDS are provided in [supplementary table 3](#sup1){ref-type="supplementary-material"}. Identified prophage regions show partial homologies to several enterobacteria phages, such as, for example, phiP27, P1, Gifsy-2, lambda, or SEN34 ([@evy168-B44]). These phage-borne loci encode important virulence determinants, such as the invasion plasmid antigen IpaH9.8, an E3 ubiquitin ligase that interferes with the host's ubiquitination pathways and facilitates colonization ([@evy168-B42]). We also noted that the majority of the 866 prophages carry transposons and IS elements that are known drivers of bacteriophage diversification ([@evy168-B13]; [@evy168-B65]). Bacteria often carry an array of prophages in their genomes. The benefits conferred by polylysogeny are poorly understood, but previous reports show that in mixed infections with phage-free bacteria, phage carriage, and especially multiple phage carriage, is highly beneficial and provides a fitness advantage during mixed infections by mediating bacteria--bacteria competition ([@evy168-B7]). Moreover, many bacteria use their prophages as weapons against competitors. Because the different temperate phages are likely to have different host ranges, this expands the range of bacterial competitors that the polylysogen can kill ([@evy168-B21]).

This strain features virulence hallmarks of *S. sonnei* such as *lpfA, ipaH9.8, gad, senB*, and *sigA* ([@evy168-B42]; [@evy168-B1]; [@evy168-B61]; [@evy168-B23]; [@evy168-B34]). We further identified an arsenal of five AR loci on the MDR-plasmid p866 ([fig. 2*A*](#evy168-F2){ref-type="fig"}), which renders this strain ß-lactamase (*blaTEM-1A*), sulfonamide (*sul2*), tetracycline (*tetB*), aminoglycoside (*aadA1*), and trimethoprim (*dfrA*) resistant ([@evy168-B66]; [@evy168-B36]).

![Comparison of *Shigella sonnei* p866 plasmid architecture and inventory with phylogenetically related *Escherichia coli* and *Shigella* plasmids. BLAST atlas ([@evy168-B47]) comparison of related *E. coli* and *Shigella* plasmids, as determined by BLASTn inferred nucleotide sequence similarities ([@evy168-B3]). (*A*) Respective gene inventories are referenced to the 113 kb MDR-plasmid p866 (black, outer circle). CDS are presented as arrows and color-coded according to plasmid origin as depicted in the legend. GC-content and -skew of p866 are depicted in the two innermost circles, in green and purple, respectively. Plasmid locations of the type IV pilus biogenesis, conjugal transfer, and five antimicrobial resistance loci, which are part of transposable elements Tn3, Tn7, and Tn10 are highlighted. The other two figures correspond to a linear representation of the five coded antimicrobial resistance loci in p866. Four of the five resistances were introduced by insertion of three transposable elements, with the notable exception of sulfonamide locus, which is an integral part of the plasmid backbone. Tn3-, Tn7-, and Tn10-associated resistance cassettes are inserted at two different locations. (*B*) Tn7 and Tn10 elements form a composite transposon, in which Tn10 disrupts Tn7, and confers tetracycline, streptomycin, and trimethoprim resistance. (*C*) Transposon Tn3 confers ß-lactamase resistance. Transposon boundaries and inverted repeats, if detected, are shown as arrows. CDS are presented as arrows and color-coded according to plasmid origin as depicted in the legend. GC-content and -skew of p866 are depicted, in green and purple, respectively.](evy168f2){#evy168-F2}

Phylogenetic Relatedness and Gene Inventory of MDR-Plasmid p866
---------------------------------------------------------------

To elucidate phylogenetic relatedness of the MDR plasmid, we performed a nucleotide BLASTn ([@evy168-B3]) search of the complete p866 plasmid sequence against the non-redundant database at NCBI. We, hereby, identified several plasmids of diverse *E. coli* and *Shigella* pathovars that share high similarity at the nucleotide level (\>99%) with a coverage of the plasmid backbones ranging from 72% to 79%. Namely, *E. coli* plasmids pHUSEC41-1, from an EAEC O104: H4 hybrid strain from the 2011 outbreak in Germany ([@evy168-B31]), pEC3I (KU932021.1), pR3521 ([@evy168-B43]), and pHUSEC411, from ExPEC O18: K1 strain PMV-1 ([@evy168-B45]). Further, *S. dysenteriae* 1 plasmids p69-3818 (strain 69-3818, Guatemala 1969) and p92-9000 (strain 92-9000, Panama 1991) ([@evy168-B38]). Here, we note that the phylogenetic closest *S. sonnei* plasmids in the NCBI repository show only ∼68% sequence coverage, as seen for plasmids pSH15sh99 (KY471628.1) or pSH15sh104 (KY471629.1).

We compared both the p866 coding capacity and plasmid architecture among these phylogenetically related plasmids, which are all of the IncB/O/K/Z incompatibility group ([@evy168-B30]). Nucleotide-level analysis using BLAST atlas ([@evy168-B47]) shows a largely syntenic shared plasmid backbone of ∼86 kb that is highly conserved ([fig. 2*A*](#evy168-F2){ref-type="fig"}). It encodes operons for type IV pilus biogenesis, conjugal transfer, and plasmid maintenance, which altogether account for more than 50% of the shared plasmid backbone. Our analysis clearly shows that microevolution in this MDR plasmid is driven by transposon (Tn) insertions into the plasmid backbone. As shown in [figure 2*A*](#evy168-F2){ref-type="fig"}, four of the five AR loci were introduced by insertion of three transposable elements that disrupt plasmid synteny: Tn3 (*blaTEM-1A*), Tn7 (*aadA1* and *dfrA*), and Tn10 (*tetB*) ([@evy168-B6]; [@evy168-B39]; [@evy168-B30]), although the *sul2* gene is part of the *E. coli* and *S. sonnei* p866 plasmid backbones. The prototypical Tn7 is plastic in its carried resistance gene cassettes and encodes seven genes (*tnsABCDE*) required for transposition ([@evy168-B46]). In case of p866 Tn7, we found that Tn7~*tnsCD*~ loci are missing, likely due to a secondary insertion of Tn10 in-between the Tn7~*tnsBE*~ ([fig. 2*B*](#evy168-F2){ref-type="fig"}). Transposon Tn3 appears intact while Tn10 lacks the left IS10 repeat, which might impair its mobility ([@evy168-B10]; [@evy168-B32]; [@evy168-B16]). Details of the respective Tn sequence compositions including inverted repeats can be found in [figure 2*B* and *C*](#evy168-F2){ref-type="fig"}.

Comparison of AR profiles among these plasmids shows that trimethoprim (*dfrA*) resistance is uniquely found in p866 as an integral component of Tn7 ([fig. 2*A*](#evy168-F2){ref-type="fig"}). Both p866 and the two *S. dysenteriae* plasmids confer *aadA1* and *tetB* resistance, though the respective streptomycin loci are found in different transposon contexts; Tn7~*aadA1*~ in p866 and Tn21~*aadA1*~ ([@evy168-B33]), in case of *S. dysenteriae* ([fig. 2*B*](#evy168-F2){ref-type="fig"}). Strain 866 carries another transposon-encoded resistance on Tn3~*blaTEM-1A*~ ([fig. 2*C*](#evy168-F2){ref-type="fig"}), a feature shared by all compared *E. coli* plasmids with the exception of pHUSEC411. In contrast, sulfonamide^R^ ([fig. 2*B*](#evy168-F2){ref-type="fig"}) was identified as an integral part of the *E. coli* plasmid backbone. The observed prevalence and mosaic structure of the transposon resistance cassettes stresses their role as major drivers of IncB/O/K/Z-type plasmid evolution. Plasmid spread into broader host populations crossing *E. coli* and *Shigella* pathovar boundaries is likely facilitated by the conjugal transfer system found on its backbone ([fig. 2*A*](#evy168-F2){ref-type="fig"}).

The emergence of MDR bacteria has been identified by the World Health Organization as a pressing global public health problem. An emerging threat is posed by the spread of antibiotic resistant *S. sonnei* isolates ([@evy168-B49]), the major culprit of human shigellosis within last decades ([@evy168-B54]; [@evy168-B25]; [@evy168-B58]), which has an exceptional ability to laterally acquire and transfer resistance genes ([@evy168-B27]; [@evy168-B18]; [@evy168-B60]; [@evy168-B57]; [@evy168-B50]). Using whole genome sequencing and typing strategies, we have elucidated the genomic make-up and phylogenetic relationship of the clinical *S. sonnei* strain 866 and identified the genomic basis of AR against five classes of antibiotics on the carried MDR-plasmid p866. The microevolution of this IncB/O/K/Z-type plasmid is driven by different Tn insertions that render strain 866 MDR. The carried conjugal transfer backbone of p866 makes it an ideal vehicle for the lateral spread of resistance loci into diverse *E. coli* and *Shigella* pathovars ([fig. 2*A*](#evy168-F2){ref-type="fig"}) and potentially other enterics of clinical importance. Monitoring emerging trends in the *S. sonnei* pathogenome evolution is thus critical to translate sequence-based information into actionable countermeasures to detect and prevent the spread of MDR resistant *Shigella* clones. Identified genome signatures of such emerging highly virulent and AR resistant clones are readily applicable for improved biosurveillance, risk assessment, and informed and improved therapeutic strategies ([@evy168-B41]; [@evy168-B48]).
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